| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |